Cite
APA Citation
Bergeat, D., Fautrel, A., Turlin, B., Merdrignac, A., Rayar, M., Meunier, B., Clement, B., Boudjema, K., Coulouarn, C., & Sulpice, L. (n.d.). lOXL2 is a prognosis biomarker and a potential therapeutic target in intrahepatic cholangiocarcinoma. HPB, 18, e863–. http://access.bl.uk/ark:/81055/vdc_100055919842.0x000009